WHAT’S ON

News

La combinació de NT-proBNP i el quocient de factors angiogènics millora la predicció de la preeclàmpsia - Dra. Carmen Garrido i Dra. Maria Nicoleta Nan
21/01/2026

The Combination of NT-proBNP and the Angiogenic Factor Ratio Improves the Prediction of Preeclampsia

The Institut de Recerca Sant Pau (IR Sant Pau) has led a multicenter study showing that incorporating the biomarker NT-proBNP, commonly used to assess cardiac function, significantly improves the abil...
Dr. Pablo Alonso
19/01/2026

OptimAP, a New Tool to Improve Antibiotic Use in Pediatric Respiratory Infections

The Sant Pau Research Institute (IR Sant Pau) has received funding from the Carlos III Health Institute (ISCIII), co-funded by the European Union through European Funds, for the technological developm...
Descobreixen com un bacteri respiratori obté lípids essencials de l’organisme humà i es dirigeix a teixits rics en greix
15/01/2026

Researchers Discover How a Respiratory Bacterium Obtains Essential Lipids From the Human Body and Targets Fat-Rich Tissues

A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for atypical pneumonia and other respiratory infections—to obtain cholester...
ISCIII
13/01/2026

Three IR Sant Pau professionals receive intensification grants to boost their research activity

The Institut de Recerca Sant Pau (IR Sant Pau) has been awarded three research activity intensification grants in the 2025 call of the Instituto de Salud Carlos III (ISCIII). This program is aimed at ...
Javier Briones_Pol Camps
12/01/2026

Sant Pau Research Institute Secures More Than €2.5 Million to Advance Two Independent Clinical Trials in Oncology and Stroke

The Sant Pau Research Institute (IR Sant Pau) will lead two new independent clinical trials in areas of high clinical complexity—hematologic oncology and acute ischemic stroke—after securing more ...
1 2 3 135

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information